Lonafarnib Boosted With Ritonavir With and Without Peginterferon Alfa-2a (PEG IFN-a) in HDV (LOWR-2)
Clinical trial NCT02430194 · COMPLETED
Trial details
- NCT number
- NCT02430194
- Sponsor
- Eiger BioPharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2017-04-18
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.